Qvanteq Bioactive Coronary Stent System First in Man (FIM) Clinical Investigation

NACompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

February 29, 2016

Study Completion Date

August 31, 2016

Conditions
Coronary Artery Disease
Interventions
DEVICE

Qvanteq bioactive coronary stent

PCI

Trial Locations (6)

1205

Cardiologie interventionnelle HUG - Hôpitaux Universitaires de Genève, Geneva

3010

Universitätsklinik für Kardiologie Schweizer Herz- und Gefässzentrum Bern, Bern

3015

Thoraxcenter Erasmus MC Universitair Medisch Centrum Rotterdam, Rotterdam

7513

Thoraxcentrum Twente, Medisch Spectrum Twente, Enschede

8032

HerzKlinik Hirslanden, Zurich

8063

Stadtspital Triemli Zürich Klinik für Kardiologie, Zurich

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Cardialysis BV

INDUSTRY

lead

Qvanteq AG

INDUSTRY